Beating bureaucracy to gain approval for research

Article Abstract:

Several measures are being taken to beat the bureaucracy, which will help the nurses undertaking research in making the entire process much simpler and free of all the approval processes, as well as the paper-based activities. The author suggests that the committees should fasten the entire process, as the nurses tend to waste a lot of their time in completing such formalities, which also affects their work to a large extent.

Records and correspondence

---

Report promises a brighter future for nursing research

Article Abstract:

The UK Clinical Research Collaboration has published a consultation document that offers a better prospect for nursing research. It proposes that pharmaceutical companies would fund the clinical research and the health-related research undertaken by the nurses.

Forecasts, trends, outlooks, Reports, Forecasts and trends, Market trend/market analysis

---

Dissemination is the forgotten element of research

Article Abstract:

The burden of dissemination lies jointly with nurses, educationists and employers and the responsibility of sharing our information and knowledge and experience with others is a major contributory factor to research.

Research and Development in the Physical, Engineering, and Life Sciences, Research and Testing Services, Medical Research, Epilepsy & Muscle Disease R&D, Administration of Public Health Programs, Health Research Programs, Medical publishing, Medicine, Experimental

Similar abstracts:

• Abstracts: A positive attitude to patient care. Reflections on practice: HCAs do the real nursing. Benchmarking essence of care using electronic patient records
• Abstracts: Delaying generic competition - Corporate payoffs and the future of Plavix. Approving the vagus-nerve stimulator for depression
• Abstracts: US marijuana laws clamping the lid on pot research. Scientists stir the pot for the right to grow marijuana. Bring the magic back to the bullets
• Abstracts: Intraperitoneal cisplatin and paclitaxel in ovarian cancer. Interferon-gamma expression is an independent prognostic factor in ovarian cancer
• Abstracts: Efficacy still uncertain for widely used supplements for arthritis. MI risks linked to rosiglitazone

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.